The Week in Review: October 30-November 3

From sleep and neuroendocrine function following TBI to new phase 3 results from a clinical trial evaluating a promising new schizophrenia treatment, here are highlights from the week in Psychiatric Times.

Related Keywords

Chepko Danil , ,Psychiatric Times ,Topline Results Reported ,Trial Evaluating Schizophrenia ,Negative Syndrome Scale ,Bidirectional Relationship Between Sleep ,Neuroendocrine Function ,Head Comparison ,Vortioxetine Versus Desvenalfaxine ,Patients With Depression ,Partial Response ,